Truist Financial Maintains Glaukos(GKOS.US) With Buy Rating

儲億銀行維持Glaukos(GKOS.US)買入評級

富途資訊 · 2024/11/06 20:31 · 評級/大行評級

Truist Financial analyst Richard Newitter maintains $Glaukos (GKOS.US)$ with a buy rating.

According to TipRanks data, the analyst has a success rate of 58.7% and a total average return of 17.8% over the past year.

AnalystRecentRatingAutoNews_211107_20241106_335117fa50ffae4b101150f65a765733f11b8c10_1730961016816420_nn_en

Furthermore, according to the comprehensive report, the opinions of $Glaukos (GKOS.US)$'s main analysts recently are as follows:

Glaukos' Q3 results surpassed consensus estimates, bolstered by an $8.8M contribution from iDose and a 12.3% increase in sales of the iStent infinite and the broader iStent portfolio within the U.S. Additionally, the company's Glaucoma business has experienced robust growth, exceeding 20% outside of the U.S.
Glaukos reported third-quarter sales that surpassed the consensus, propelled by the performance of iDose and international MIGS sales. The company's management improved their sales forecast by $5 million at the midpoint, equivalent to the extent of the overachievement. There is anticipation for continuous positive momentum for iDose into the fourth quarter and towards 2025.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

儲億銀行分析師Richard Newitter維持$Glaukos (GKOS.US)$買入評級。

根據TipRanks數據顯示，該分析師近一年總勝率為58.7%，總平均回報率為17.8%。

AnalystRecentRatingAutoNews_211107_20241106_335117fa50ffae4b101150f65a765733f11b8c10_1730961016816420_nn_tc

此外，綜合報道，$Glaukos (GKOS.US)$近期主要分析師觀點如下：

Glaukos第三季度的業績超過了市場預期，這得益於iDose的880萬美元捐款，以及iStent infinite和更廣泛的iStent在美國境內的銷售額增長了12.3％。此外，該公司的青光眼業務實現了強勁增長，在美國以外地區超過20％。
Glaukos報告稱，受iDose和國際MIGS銷售業績的推動，第三季度的銷售額超過了市場預期。該公司的管理層在中點將銷售預測提高了500萬美元，相當於超額完成的程度。預計iDose將持續保持積極勢頭，直至第四季度和2025年。

提示:

TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。

TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。

分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。

總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

Truist Financial Maintains Glaukos(GKOS.US) With Buy Rating

Truist Financial Maintains Glaukos(GKOS.US) With Buy Rating

風險及免責聲明

聲明